Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine

Across human and veterinary medicine, vaccines against only two retroviral infections have been brought to market successfully, the vaccines against feline leukaemia virus (FeLV) and feline immunodeficiency virus (FIV). FeLV vaccines have been a global success story, reducing virus prevalence in cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Bęczkowski, Paweł M., Harris, Matthew, Techakriengkrai, Navapon, Beatty, Julia A., Willett, Brian J., Hosie, Margaret J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327927/
https://www.ncbi.nlm.nih.gov/pubmed/25613718
http://dx.doi.org/10.1016/j.vaccine.2015.01.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327927/
https://www.ncbi.nlm.nih.gov/pubmed/25613718
http://dx.doi.org/10.1016/j.vaccine.2015.01.028

Ejemplares similares